Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 2
2009 1
2010 1
2012 1
2013 1
2014 3
2015 2
2016 1
2019 1
2020 1
2022 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Intrathecal B-cell activation in LGI1 antibody encephalitis.
Lehmann-Horn K, Irani SR, Wang S, Palanichamy A, Jahn S, Greenfield AL, Dandekar R, Lepennetier G, Michael S, Gelfand JM, Geschwind MD, Wilson MR, Zamvil SS, von Büdingen HC. Lehmann-Horn K, et al. Among authors: palanichamy a. Neurol Neuroimmunol Neuroinflamm. 2020 Feb 6;7(2):e669. doi: 10.1212/NXI.0000000000000669. Print 2020 Mar. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32029531 Free PMC article.
B cells in the pathogenesis and treatment of rheumatoid arthritis.
Marston B, Palanichamy A, Anolik JH. Marston B, et al. Among authors: palanichamy a. Curr Opin Rheumatol. 2010 May;22(3):307-15. doi: 10.1097/BOR.0b013e3283369cb8. Curr Opin Rheumatol. 2010. PMID: 20090526 Free PMC article. Review.
Failure of B Cell Tolerance in CVID.
Richardson CT, Slack MA, Dhillon G, Marcus CZ, Barnard J, Palanichamy A, Sanz I, Looney RJ, Anolik JH. Richardson CT, et al. Among authors: palanichamy a. Front Immunol. 2019 Dec 10;10:2881. doi: 10.3389/fimmu.2019.02881. eCollection 2019. Front Immunol. 2019. PMID: 31921145 Free PMC article. Clinical Trial.
Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
Schett G, Loza MJ, Palanichamy A, FitzGerald O, Ritchlin C, Bay-Jensen AC, Nielsen SH, Gao S, Hsia EC, Kollmeier AP, Xu XL, Baribaud F, Sweet K. Schett G, et al. Among authors: palanichamy a. Rheumatol Ther. 2022 Aug;9(4):1247-1248. doi: 10.1007/s40744-022-00470-9. Rheumatol Ther. 2022. PMID: 35779224 Free PMC article. No abstract available.
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
Schett G, Loza MJ, Palanichamy A, FitzGerald O, Ritchlin C, Bay-Jensen AC, Nielsen SH, Gao S, Hsia EC, Kollmeier AP, Xu XL, Baribaud F, Sweet K. Schett G, et al. Among authors: palanichamy a. Rheumatol Ther. 2022 Aug;9(4):1017-1030. doi: 10.1007/s40744-022-00444-x. Epub 2022 Mar 30. Rheumatol Ther. 2022. PMID: 35352313 Free PMC article.
18 results